News & Views

|
News, Press Release
|
Category: News, Press Release

Anova partners with Throne Biotechnologies for the development and management of early access program for Stem Cell Educator Therapy

Anova today announced a partnership with Throne Biotechnologies, Inc. (Throne Bio, ThroneBio.com) to provide early access to Stem Cell Educator (SCE) Therapy for patients with Type 1 Diabetes and other life-threatening autoimmune diseases. “Our partnership with Throne is a further demonstration of Anova’s commitment to increasing access to promising new treatments for patients in need,’ said Martin Walsh, President at…
|
News, Press Release
|
Category: News, Press Release

Anova Acquires Corlexia Clinical Services And Expands Leadership Team

Anova Enterprises, Inc. (Anova), an organization dedicated to accelerating promising treatments to market with its transformative AnovaOS™ technology platform, and the industry’s first collaborative ‘learning system,’ and Corlexia Clinical Services, a contract research organization focused on complex clinical trials for patients with complex neurology and oncology diseases today announced the acquisition of Corlexia by Anova. The acquisition adds further depth…
|
News
|
Category: News

Anova further expands international footprint, partnering with Korea Orphan & Essential Drug Center (KODC) to develop legislative framework for compassionate use of investigational products in South Korea

Anova today announced a partnership with the Korea Orphan & Essential Drug Center (KODC) to develop a legislative framework for compassionate use of investigational product, to help increase access to investigational treatments for patients in need across South Korea.
|
Events, News
|
Category: Events, News

Meet the Anova team at Expanded Access Summit 2020. Hear from Anova CEO Chris Beardmore on how to increase access to promising new treatments

Meet the Anova team at Expanded Access Summit 2020. Hear from Anova CEO Chris Beardmore on how to increase access to promising new treatments for compassionate use, significantly reducing the cost of delivering these pathways, and how Anova is helping to collect high quality data to support regulatory submissions.

Register today, connect your research network, 
and accelerate your research program.

Up arrow